I thought these claims sounded exaggerated too until I tried retatrutide myself and tracked 127 biomarkers
Artificial intelligence in diagnosis of knee osteoarthritis and prediction of arthroplasty outcomes: a review
Get VIP Medical Treatment with IV Drips in the comfort of your home or location of your choice
This is an update of an article originally published July 2018.
Clinical Safety Screens Performed MTC personal AND family history in the comorbidity multi-select MEN-2 personal AND family history separately Substance / opioid screen with three-month opiate window + free-text dose, frequency, dates Suicidality and recent suicide attempt as exclusionary opt-out Active cancer treatment and cancer-free-for-five-years exclusionary End-stage kidney and liver disease opt-out Severe GI screen (gastroparesis, blockage, IBD) Pancreatitis history in the multi-select Self-reported blood pressure range and resting heart rate Past 2-month GLP-1 use (semaglutide / tirzepatide / none) No validated PHQ-2 or PHQ-9 depression instrument suicidality is captured as a binary exclusionary opt-out and severe depression is a checkbox on the comorbidity multi-select, but the validated brief screening scale is not used
PlexusDx recommends discussing all medication questions with your breastfeeding medicine specialist or lactation consultant before initiating therapy, and scheduling regular check-ins to assess both maternal response and any signs of infant concern
